NO752109L - - Google Patents
Info
- Publication number
- NO752109L NO752109L NO752109A NO752109A NO752109L NO 752109 L NO752109 L NO 752109L NO 752109 A NO752109 A NO 752109A NO 752109 A NO752109 A NO 752109A NO 752109 L NO752109 L NO 752109L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- acid
- compounds
- isopropyl
- reaction
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 11
- 150000003839 salts Chemical group 0.000 claims description 10
- 150000007513 acids Chemical class 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- ORIBUSCBDFDAIQ-GYYYEOQOSA-N methyl (6ar,9r)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate Chemical compound C1=CC(C2[C@H](NC[C@@H](C2)C(=O)OC)C2)=C3C2=CNC3=C1 ORIBUSCBDFDAIQ-GYYYEOQOSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical compound OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000002746 orthostatic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- HYHBKLWDTGTBME-UHFFFAOYSA-N pyrazin-1-ium;chloride Chemical compound Cl.C1=CN=CC=N1 HYHBKLWDTGTBME-UHFFFAOYSA-N 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH853374A CH602767A5 (xx) | 1974-06-21 | 1974-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO752109L true NO752109L (xx) | 1975-12-23 |
Family
ID=4341635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO752109A NO752109L (xx) | 1974-06-21 | 1975-06-13 |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5113798A (xx) |
| AT (1) | AT356292B (xx) |
| AU (1) | AU503060B2 (xx) |
| BE (1) | BE830441A (xx) |
| CA (1) | CA1057285A (xx) |
| DD (1) | DD118088A5 (xx) |
| DE (1) | DE2525962A1 (xx) |
| DK (1) | DK140670B (xx) |
| ES (1) | ES438704A1 (xx) |
| FI (1) | FI751753A (xx) |
| FR (1) | FR2275212A1 (xx) |
| GB (1) | GB1499420A (xx) |
| HU (1) | HU169390B (xx) |
| IE (1) | IE41564B1 (xx) |
| IL (1) | IL47522A (xx) |
| NL (1) | NL7507177A (xx) |
| NO (1) | NO752109L (xx) |
| PH (1) | PH13361A (xx) |
| SE (1) | SE7506758L (xx) |
| YU (1) | YU157375A (xx) |
| ZA (1) | ZA753967B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH601321A5 (xx) * | 1975-01-06 | 1978-07-14 | Sandoz Ag | |
| CH619468A5 (xx) * | 1976-01-12 | 1980-09-30 | Sandoz Ag | |
| GB0409785D0 (en) | 2004-04-30 | 2004-06-09 | Resolution Chemicals Ltd | Preparation of cabergoline |
| GB0505965D0 (en) | 2005-03-23 | 2005-04-27 | Resolution Chemicals Ltd | Preparation of cabergoline |
| US7339060B2 (en) | 2005-03-23 | 2008-03-04 | Resolution Chemicals, Ltd. | Preparation of cabergoline |
-
1975
- 1975-06-11 DE DE19752525962 patent/DE2525962A1/de not_active Withdrawn
- 1975-06-12 FI FI751753A patent/FI751753A/fi unknown
- 1975-06-12 DK DK266475AA patent/DK140670B/da unknown
- 1975-06-12 SE SE7506758A patent/SE7506758L/xx unknown
- 1975-06-13 NO NO752109A patent/NO752109L/no unknown
- 1975-06-16 GB GB25527/75A patent/GB1499420A/en not_active Expired
- 1975-06-17 NL NL7507177A patent/NL7507177A/xx not_active Application Discontinuation
- 1975-06-17 PH PH17276A patent/PH13361A/en unknown
- 1975-06-17 FR FR7518879A patent/FR2275212A1/fr active Granted
- 1975-06-19 IE IE1375/75A patent/IE41564B1/en unknown
- 1975-06-19 ES ES438704A patent/ES438704A1/es not_active Expired
- 1975-06-19 YU YU01573/75A patent/YU157375A/xx unknown
- 1975-06-19 AU AU82273/75A patent/AU503060B2/en not_active Expired
- 1975-06-19 IL IL47522A patent/IL47522A/en unknown
- 1975-06-19 BE BE157509A patent/BE830441A/xx unknown
- 1975-06-19 DD DD186767A patent/DD118088A5/xx unknown
- 1975-06-19 HU HUSA2806A patent/HU169390B/hu unknown
- 1975-06-20 CA CA229,783A patent/CA1057285A/en not_active Expired
- 1975-06-20 AT AT473575A patent/AT356292B/de not_active IP Right Cessation
- 1975-06-20 JP JP50074583A patent/JPS5113798A/ja active Pending
- 1975-06-20 ZA ZA3967A patent/ZA753967B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2525962A1 (de) | 1976-01-08 |
| ES438704A1 (es) | 1977-06-01 |
| DK140670C (xx) | 1980-03-17 |
| PH13361A (en) | 1980-03-20 |
| FI751753A (xx) | 1975-12-22 |
| DK266475A (xx) | 1975-12-22 |
| CA1057285A (en) | 1979-06-26 |
| JPS5113798A (xx) | 1976-02-03 |
| DK140670B (da) | 1979-10-22 |
| IE41564L (en) | 1975-12-21 |
| DD118088A5 (xx) | 1976-02-12 |
| AU503060B2 (en) | 1979-08-23 |
| IL47522A (en) | 1977-12-30 |
| BE830441A (fr) | 1975-12-19 |
| ATA473575A (de) | 1979-09-15 |
| HU169390B (xx) | 1976-11-28 |
| SE7506758L (sv) | 1975-12-22 |
| AU8227375A (en) | 1976-12-23 |
| FR2275212B1 (xx) | 1979-08-10 |
| ZA753967B (en) | 1977-01-26 |
| GB1499420A (en) | 1978-02-01 |
| YU157375A (en) | 1982-05-31 |
| IL47522A0 (en) | 1975-08-31 |
| IE41564B1 (en) | 1980-01-30 |
| AT356292B (de) | 1980-04-25 |
| NL7507177A (nl) | 1975-12-23 |
| FR2275212A1 (fr) | 1976-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6426346B1 (en) | 6-membered aromatics as factor Xa inhibitors | |
| US4868331A (en) | Substituted amino-5,6,7,8-tetrahydronaphthyl-oxyacetic acids, processes for their preparation and their use as medicaments | |
| KR950007753B1 (ko) | 신규 인돌 유도체, 그 제조방법 및 그를 함유하는 의약 조성물 | |
| ES2299090T3 (es) | Antagonistas de bradiquinina no peptidicos y composiciones farmaceuticas de los mismos. | |
| US7989494B2 (en) | Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide | |
| NO153054B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cykliske iminosyrer | |
| NO151876B (no) | Fremgangsmaate og anordning for foring av dyr | |
| US6080768A (en) | Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system | |
| NO752109L (xx) | ||
| NO752493L (xx) | ||
| NO744175L (xx) | ||
| EP1294684A2 (en) | THROMBIN OR FACTOR Xa INHIBITORS | |
| NO139169B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer | |
| NO124430B (xx) | ||
| CN116262735A (zh) | 新型氧代吡啶类化合物及其制备方法和用途 | |
| US3499906A (en) | 5,9-diethyl-2'-hydroxy-2-substituted-6,7-benzomorphans | |
| US4791115A (en) | 2,6-dimethyl-8α-pivaloylamino-9,10-didehydro-ergoline | |
| US2970147A (en) | 3-hydroxy-nu-(heterocyclic-ethyl)-morphinans | |
| NO135421B (xx) | ||
| US2912436A (en) | Brominated alkaloids | |
| US3583992A (en) | 1-methyl-d-lysergic acid-dihydroxy-alkyl-amides | |
| CN103420984B (zh) | 作为前药的达比加群酯衍生物及其制备方法和用途 | |
| CN103420983B (zh) | 达比加群酯衍生物及其制备方法和用途 | |
| US4035501A (en) | N-lysergyl-amino-pyridines | |
| CN103420994B (zh) | 作为前药的达比加群酯衍生物及其制备方法和用途 |